Precigen (PGEN) Change in Cash (2012 - 2026)
Precigen (PGEN) reported Change in Cash of -$22.8 million for Q1 2026, up 3.01% year-over-year from -$22.1 million in Q1 2025, and down 243.0% quarter-over-quarter from $15.9 million in Q4 2025.
Precigen (PGEN) Change in Cash (2012 - 2026) Analysis & Trends
Precigen (PGEN) has 15 years of Change in Cash data on file, last reported at -$22.8 million in Q1 2026.
- Change in Cash for Q1 2026 came in at -$22.8 million, up 3.01% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.4 million (up 112.17% YoY), and the FY2025 annual result was $717000.0, down 96.69% from the prior year.
- Change in Cash eased to -$22.8 million in Q1 2026 per PGEN's latest filing, from $15.9 million in the prior quarter.
- Over five years, Change in Cash peaked at $42.0 million in Q3 2022 and troughed at -$43.3 million in Q4 2022.
- A 5-year average of -$2.1 million and a median of -$2.5 million in 2023 frame the typical range for Change in Cash.
- On a YoY basis, Change in Cash climbed as much as 691.23% in 2022 and fell as far as 3758.5% in 2022.
- A 5-year view of Change in Cash shows it stood at -$43.3 million in 2022, then surged by 94.25% to -$2.5 million in 2023, then jumped by 292.68% to $4.8 million in 2024, then surged by 232.05% to $15.9 million in 2025, then sank by 243.0% to -$22.8 million in 2026.
- Business Quant data shows PGEN's Change in Cash at -$22.8 million in Q1 2026, $15.9 million in Q4 2025, and $562000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | 2.44 Mn |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | 623.00 Mn |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | -2.44 Mn |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | 417.10 Mn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | -45.97 Mn |
| 10 | Precigen | 1.32 Bn | 1.32 Bn | 20.69 Mn | -22.75 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -22.75 Mn |
| Dec 31, 2025 | 15.91 Mn |
| Sep 30, 2025 | 562,000.00 |
| Jun 30, 2025 | 7.70 Mn |
| Mar 31, 2025 | -23.46 Mn |
| Dec 31, 2024 | 4.79 Mn |
| Sep 30, 2024 | 15.12 Mn |
| Jun 30, 2024 | -8.14 Mn |
| Mar 31, 2024 | 9.90 Mn |
| Dec 31, 2023 | -2.49 Mn |
| Sep 30, 2023 | -6.62 Mn |
| Jun 30, 2023 | -6.99 Mn |
| Mar 31, 2023 | -24.65 Mn |
| Dec 31, 2022 | -43.28 Mn |
| Sep 30, 2022 | 41.98 Mn |
| Jun 30, 2022 | 9.17 Mn |
| Mar 31, 2022 | -2.61 Mn |
| Dec 31, 2021 | 1.18 Mn |
| Sep 30, 2021 | 5.31 Mn |
| Jun 30, 2021 | 9.06 Mn |